Keith Sudheimer

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression

Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT-TRD) induces rapid remission from treatment-resistant depression in a double-blinded, randomized, and controlled trial.

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

Functional connectivity changes with rapid remission from moderate-to-severe major depressive disorder

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

Cortisol, cytokines, and hippocampal volume interactions in the elderly

Psychosocial predictors of salivary cortisol among older adults with depression